Furthermore, Prolacta says it saves . Reduce hospital costs 5,6. Prolacta's neonatal nutritional products, when used as part of an exclusive human milk diet 1, are clinically proven to improve health outcomes 2,3,4 and reduce hospital costs 2,5 for critically . ** Preterm infants fed cow's milk-derived fortifier had adverse outcomes despite a base diet of only . Despite the added cost of donor human milk and donor milk-derived fortifier, an EHMD is cost effective. 2 3 4 a fourth study demonstrated 27. . Prolacta makes a difference when it is all on the line By unlocking the biological power of human milk, we change the lives of critically ill infants around the world.

. The cost of Prolacta's product during a single premature baby's hospital stay is between $5,600 and $10,000. Prolacta's neonatal nutritional products, when used as part of an exclusive human milk diet 1, are clinically proven to improve health outcomes 2,3,4 and reduce hospital costs 2,5 for critically . Cost-benefit analysis; Conferences; Parents. in three recent studies, the use of prolacta's fortifiers as part of an exclusive human milk diet (ehmd) 1 led to statistically significant decreases (weighted average of 9.7%) in the serious lung. .

1800 Highland Ave. Duarte, CA 91010. Health economic analyses will be made to evaluate the costs and benefits of an introduction of human milk-based fortifier in neonatal intensive care units (NICUs). Humavant human milk fortifier from Prolacta Bioscience is the only HMF that is 100% human milk based. Although the human milk fortifier costs more than cows-milk-based fortifier, six fewer total parenteral nutrition (TPN) days translates to a savings of $500 per infant per day for the babies they examined, Sasinski says. Study Finds Prolacta's Fortifiers as Part of Exclusive Human Milk Diet (EHMD) Reduce Comorbidities and Shorten Length of NICU Stay; Benefits Help . Policy related questions +800 . When used as part of an EHMD, Prolacta's neonatal nutritional products are clinically proven to improve health outcomes 2,3,4 and reduce hospital costs 5,6 for critically ill, extremely premature . Prolacta charges $180 an ounce for its product. Assad M, Elliott MJ, Abraham JH. "We were really pleased," she says. A systematic review has just been published which compares the outcomes of milk fortification with bovine-milk derived fortifier and human-milk derived fortifier. A 4-ounce bottle of donor milk costs $56, whereas a comparable bottle of Prolacta's fortifier costs between $125 and $312. ( Grace E, et al. Overview. and donor milk-derived fortifier, an EHMD is cost effective.17 Up to 10 fewer days to achieve full feeds for VLBW babies fed an EHMD compared to VLBW babies on CMD (P<.001)17 94% Those in the Prolacta fortifier group showed a 16.5% decrease in incidence of BPD (48.5%, compared with 65%; P = 0.018). Prolacta funded and administered research that showed that use of the fortifier significantly reduced the risk of necrotizing enterocolitis in extremely premature infants, and the product took off. Adelaide South Australia Australia. Prolacta was the first company to develop a 100% human milk-based fortifier. I was absolutely excited and fascinated that Prolacta offered a concentrated human breast milk product." The Laus advocated for Prolacta's 100 percent human milk-based fortifier instead of one made with cow milk, and Lucy was given Prolact+ H2MF. . The resulting benefit of Prolacta's fortifiers, as part of an EHMD, to preterm infant health and the reductions in the cost of care, as demonstrated in this study, are being replicated worldwide by. The study compared whether preterm infants benefited from Prolacta's human milk-based fortifier supplementation compared to cow/bovine milk-based fortifiers and whether the higher purchase costs . Design of the N-forte study. The resulting benefit of Prolacta's fortifiers, as part of an EHMD, to preterm infant health and the reductions in the cost of care, as demonstrated in this study, are being replicated worldwide by. in three recent studies, the use of prolacta's fortifiers as part of an exclusive human milk diet (ehmd) 1 led to statistically significant decreases (weighted average of 9.7%) in the serious lung disease bronchopulmonary dysplasia (bpd) among premature infants compared to those fed cow milk-based fortifiers. The switch to Prolacta is yielding cost savings, as well. Early and appropriate advancement of fortification is achievable with an exclusive human milk diet (EHMD) and has been associated with weight gain exceeding targeted standards. Preterm infants fed cow's milk-derived fortifier had adverse outcomes despite a base diet of only mother's own milk. Although the human milk fortifier costs more than cows-milk-based fortifier, six fewer total parenteral nutrition (TPN) days translates to a savings of $500 per infant per day for the babies they examined, Sasinski says. That price tag leaves some with a sour taste, but Prolacta counters that it takes up to 10 ounces of human donor breast milk to make one ounce of fortifier. To date, 63,000 infants throughout the world have directly benefitted from Prolacta's products. In this session, Terry Johnson will discuss the benefits of a 100% human milk-based diet for extremely premature infants. What to expect in the NICU; Importance of NICU nutrition; How to advocate for your baby; . A bottle of the fortifier can cost $125 to $312, depending on the caloric formulation. Email: info@prolacta.com. *See bottle label for added minerals **Data on file . Prolacta funded and administered research that showed that use of the fortifier significantly reduced the risk of necrotizing enterocolitis in extremely premature infants, and the product took off. Reduce hospital costs 5,6; For a copy of Prolacta's EHMD Protocol, . It has, of late, announced various donations to charity partners. Please be advised that Prolacta does not sell, share, disclose or exploit your personal information to third parties for a third parties' direct marketing purposes. What types of tests will be run on my baby in the NICU? Key cost and resource use parameters. Cost of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants.

2012;7(1):29-37. doi:10.1089/bfm.2011 . In terms of looking beyond the actual price tag and looking at clinical outcomes, we have found the Prolacta to be more cost-effective because since we started it, we have significantly reduced our NEC rates (which is a huge cost savings), reduced our length of stay, late onset sepsis, and BPD rates. BPD Increases Hospital Stays and Health Care Costs 2 Learn more >> Optimize Growth. Different strengths of human milk fortifier are available. This is a randomised controlled multi-centre trial comparing the effect of diet supplementation of a human breast milk-based nutrient fortifier (H2MF) with standard bovine protein-based nutrient fortifier in 222 extremely preterm infants (born before gestational week 28+0) exclusively fed with human breast milk (own mothers milk and/or donor milk). She is now a healthy, active toddler, who loves to eat and is on the right growth trajectory . processing facility that claims it can provide for 100% of the domestic market at a fraction of Prolacta's cost. 1. . Reduce hospital costs 5,6; For a copy of Prolacta's EHMD Protocol, email info@prolacta.com. "Despite the added cost of donor human milk and donor milk-derived fortifier, an EHMD is cost-effective. Reduce Hospital Costs. All costs were expressed in 2016 USD prices, updated using the medical care component of the Consumer Price Index .

(Today, Prolacta's product is not sold by the ounce, the company says. The Prolact CR can be given as a bolus prior to the feeding. 2015;36(3):216-220. 3. In this study, the infants with BPD may have benefited the most from the addition of Prolacta's cream fortifier, with 17 fewer days in the NICU, . A 100% human milk-based diet can contribute to increased survival rates1 and reduce the overall cost of care for very low birth weight (VLBW) infants under 1250 g. 2 The Prolacta Bioscience line of products helps maintain an exclusive human milk diet and can decrease costly complications associated with the intake of cow milk-based products. View products The exact product used is likely to differ according to local . L.A. Times, Provision of DM or Prolacta fortifier is not based on the family's ability to pay; this therapy is provided and if not covered by 3rd party payers, TCH absorbs the . -- Prolacta Bioscience Applauds Study Comparing Human Milk-Based Fortifier versus Cow Milk-Based Fortifier Fed to Infants Born at 28 Weeks Gestation or Less -- July 27, 2011 09:17 AM Eastern . When used as part of an exclusive human milk diet (EHMD) [1], Prolacta's neonatal nutritional products are clinically proven to improve health outcomes [2], [3], [4] and reduce hospital costs [5 . Prolacta estimates that the cost of feeding an infant the fortifier can range from $5,600 to $10,000 per . In past 2+ years we have used Prolacta fortifier up to 1500 gm/34-35 weeks gestational age, then transitioned to other liquid fortifiers A 100% human milk-based diet can increase survival 1 and reduce the overall cost of care for very low birth weight (VLBW) infants under 1250 g. 2. The most-recent donation is $7,500 going to the Make-a-Wish Foundation as part of an agreement signed last fall where Prolacta . Type: Fact Sheet Download the resource to learn how Prolacta Bioscience's line of products help maintain an exclusive human milk diet and decrease costly complications associated with the intake of cow milk-based products. All other products labeled "Human Milk . Prolacta charges a substantial premium for its product. More than 20 clinical studies with more than 5,000 premature infants have demonstrated the effectiveness of Prolacta's 100% human milk-based nutritional products. What types of tests will be run on my baby in the NICU? When used as part of an EHMD, Prolacta's neonatal nutritional products are clinically proven to improve health outcomes 2,3,4 and reduce hospital costs 5,6 for critically ill, extremely premature infants weighing between 500-1,250g (1 lb 1 oz to 2 lbs 12 oz) at birth, in the NICU, as compared to cow milk-based fortifier or cow milk-based . 4 . Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. Human Milk-Based Fortifier Cost/Benefits Recent cost analysis predicts savings of 3.9 NICU days and $8,167 per patient, based on cost . Instead, cost varies by gestational age and weight, and averages $120 per day.) This method has not been studied, so it is not . Abstract Objective: This study evaluated the cost-effectiveness of a 100% human milk-based diet composed of mother's milk fortified with a donor human milk-based human milk fortifier (HMF) versus mother's milk fortified with bovine milk-based HMF to initiate enteral nutrition among extremely premature infants in the neonatal intensive care unit (NICU). Level 5, City Central, Tower 2 121 King William Street. . View products The cost of the EHMD was provided by Prolacta Bioscience. Prolacta is the first and only company to provide a human milk fortifier made from 100% human milk,* Prolact+ H 2 MF human milk fortifier (human, pasteurized), which is then sold to hospitals. J Perinatol. Prolact+H 2 MF , from Prolacta Bioscience, is the first and only HMF made from 100 percent human milk -- the H 2 stands for (human) Human Milk Fortifier. Prolacta Bioscience sells a fortifier product made from human milk for premature babies in neonatal ICUs. Safety and efficacy of human milk-based fortifier in enterally fed . Policy related questions (844) 707-7482 2012:7;29-37 12 Cristofalo EA, Schanler RJ, Blanco CL, Sullivan S, Trawoeger R, et al. All of our products are clinically proven to improve health and reduce complications 1 23 when used as part of an Exclusive Human Milk Diet. A 100% human milk-based diet can increase survival1 and reduce the overall cost of care for very low birth weight (VLBW) infants under 1250 g.2 Download the resource to learn how Prolacta Bioscience's line of products help maintain an exclusive human milk diet and decrease costly complications associated with the intake of cow milk-based products.2 Please be advised that Prolacta does not sell, share, disclose or exploit your personal information to third parties for a third parties' direct marketing purposes. Prolacta makes a difference when it is all on the line By unlocking the biological power of human milk, we change the lives of critically ill infants around the world. Study: Tracking and reducing bronchopulmonary dysplasia following implementation of a novel prevention bundle Breast milk fortifiers, a new systematic review. The active group will receive a human milk-based nutrient fortifier (Humavant +6, Prolacta Bioscience, California, USA). When used as part of an exclusive human milk diet (EHMD) 1, Prolacta's neonatal nutritional products are clinically proven to improve health outcomes 2, 3, 4 and reduce hospital costs 5, 6 for . Page 13 xxx00.#####.ppt 8/6/2017 2:56:56 PM . (Today, Prolacta's product is not sold by the ounce, the company says. Prolacta makes a difference when it is all on the line By unlocking the biological power of human milk, we change the lives of critically ill infants around the world. of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk-based fortifier. All of our products are clinically proven to improve health and reduce complications 1 23 when used as part of an Exclusive Human Milk Diet. a 100% human milk-based diet can contribute to increased survival rates1and reduce the overall cost of care for very low birth weight (vlbw) infants between 500 and 1250 g.2the prolacta bioscience line of products helps maintain an exclusive human milk diet and can decrease costly complications associated with the intake of cow milk- based The process used to produce Prolacta products is not compliant with NICE clinical guidance (CG93, NICE 2010) on the operation of donor milk banks. Posted on 21 September 2020 by Keith Barrington. Methods. All of our products are clinically proven to improve health and reduce complications 1 23 when used as part of an Exclusive Human Milk Diet. 2; . Human Milk Fortifier Prolacta Term Human milk enriched with vitamins and minerals Displacement of breast milk Cost Research: Decrease NEC in the NICU Units which had high NEC rate, but result is slower weight gain and growth, and increase length of stay Those in the Prolacta fortifier group showed a 16.5% decrease in incidence of BPD (48.5%, compared with 65%; P = 0.018). When used as part of an exclusive human milk diet (EHMD) 1, Prolacta Bioscience's neonatal nutritional products are clinically proven to improve health outcomes 2,3,4 and reduce hospital costs 5,6 . Breastfeed Med . Policy related questions (844) 707-7482 Prolacta Bioscience estimate that it would cost between 94-131.00/day to feed a very low birthweight infant an exclusive human milk diet using Prolacta human milk-based fortifier. duarte, calif., nov. 12, 2019 (globe newswire) -- new research demonstrates that an exclusive human milk diet (ehmd) 1, including a 100% donor breastmilk-based fortifier, prolact+ h 2 mf,. Table 2. Symposium Highlights. 2. In the webinar there are four methods discussed. 2; . Breastfeed Med . United States. She will summarize the mounting body of compelling evidence demonstrating that an exclusively human milk diet leads to improved health outcomes and cost savings in this fragile patient population, through a reduced incidence and severity of comorbidities. The switch to Prolacta is yielding cost savings, as well. BPD Increases Hospital Stays and Health Care Costs Type: Fact Sheet Methods: A net expected costs calculator . Please be advised that Prolacta does not sell, share, disclose or exploit your personal information to third parties for a third parties' direct marketing purposes. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. View products For a copy of Prolacta's EHMD Protocol, . Instead, cost varies by gestational age and weight, and averages $120 per day.) developed in conjunction with independent clinicians, registered dieticians, nurses, and neonatologists, prolacta's ehmd protocol is backed by 15 years of clinical experience and more than 20. Two of the methods can be used to add the cream to fortified donor breastmilk/maternal breastmilk and two of the methods are specific to unfortified donor breastmilk/maternal breastmilk. The study included 293 infants . "Proven as a safe and effective caloric fortifier to boost growth in preemies, Prolact CR remains the only caloric fortifier made from 100 percent donor human milk cream, instead of cow milk . To offset the costs of processing, Prolacta provides to Texas Children's Hospital a $1 credit per ounce of milk donated. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants.